# Safety Study of Oral Vinorelbine in Subjects With Non-Hematologic Malignancies

> **NCT00641160** · PHASE1 · UNKNOWN · sponsor: **Metronome Therapeutics** · enrollment: 12 (estimated)

## Conditions studied

- Nonhematologic Malignancies

## Interventions

- **DRUG:** vinorelbine tartrate
- **DRUG:** vinorelbine tartrate
- **DRUG:** vinorelbine tartrate

## Key facts

- **NCT ID:** NCT00641160
- **Lead sponsor:** Metronome Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-03
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2008-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00641160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00641160, "Safety Study of Oral Vinorelbine in Subjects With Non-Hematologic Malignancies". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00641160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*